| National lung screening trial: variability in nodule detection rates in chest CT studies. |
23592767
|
Pinsky PF, Gierada DS, Nath PH, Kazerooni E, Amorosa J |
Radiology |
2013 |
NLST |
| Selection criteria for lung-cancer screening. |
23425165
|
Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, Berg CD |
N. Engl. J. Med. |
2013 |
NLST |
| Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up. |
23280348
|
Park ER, Gareen IF, Jain A, Ostroff JS, Duan F, Sicks JD, Rakowski W, Diefenbach M, Rigotti NA |
Cancer |
2013 |
NLST |
| Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. |
23513242
|
Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, Misumi S, Kwon KS |
Radiology |
2013 |
NLST |
| Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: the model used by the American College of Radiology arm of the National Lung Screening Trial. |
22982342
|
Gareen IF, Sicks JD, Jain AA, Moline D, Coffman-Kadish N |
Contemp Clin Trials |
2013 |
NLST |
| Targeting of low-dose CT screening according to the risk of lung-cancer death. |
23863051
|
Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA |
N. Engl. J. Med. |
2013 |
NLST |
| Effective dose assessment for participants in the National Lung Screening Trial undergoing posteroanterior chest radiographic examinations. |
23789668
|
Kruger R, Flynn MJ, Judy PF, Cagnon CH, Seibert JA |
AJR Am J Roentgenol |
2013 |
NLST |
| The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. |
24037918
|
Pinsky PF, Church TR, Izmirlian G, Kramer BS |
Cancer |
2013 |
NLST |
| ROC curves for low-dose CT in the National Lung Screening Trial. |
24009092
|
Pinsky PF, Gierada DS, Nath H, Kazerooni EA, Amorosa J |
J Med Screen |
2013 |
NLST |
| Individual variations in serum melatonin levels through time: implications for epidemiologic studies. |
24376664
|
Nogueira LM, Sampson JN, Chu LW, Yu K, Andriole G, Church T, Stanczyk FZ, Koshiol J, Hsing AW |
PLoS ONE |
2013 |
PLCO |
| Telomere length and risk of glioma. |
24231251
|
Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA |
Cancer Epidemiol |
2013 |
PLCO |
| The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. |
24115361
|
Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK |
J. Natl. Cancer Inst. |
2013 |
PLCO |
| Prospective study of the relationship between coffee and tea with colorectal cancer risk: the PLCO Cancer Screening Trial. |
23907431
|
Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J |
Br. J. Cancer |
2013 |
PLCO |
| Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. |
24089460
|
Mir MC, Stephenson AJ, Grubb RL, Black A, Kibel AS, Izmirlian G |
Cancer Epidemiol. Biomarkers Prev. |
2013 |
PLCO |
| Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial. |
23993734
|
Hocking WG, Tammemagi MC, Commins J, Oken MM, Kvale PA, Hu P, Ragard LR, Riley TL, Pinsky P, Beck TM, Prorok PC |
Lung Cancer |
2013 |
PLCO |
| Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. |
23624999
|
Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL, Hofmann JN, Chow WH, Purdue MP |
Am. J. Epidemiol. |
2013 |
PLCO |
| Association of obesity with cardiovascular disease mortality in the PLCO trial. |
23632233
|
Jiang J, Ahn J, Huang WY, Hayes RB |
Prev Med |
2013 |
PLCO |
| Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. |
23559420
|
Barocas DA, Grubb R, Black A, Penson DF, Fowke JH, Andriole G, Crawford ED |
Cancer |
2013 |
PLCO |
| Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. |
23248253
|
Drescher CW, Shah C, Thorpe J, O'Briant K, Anderson GL, Berg CD, Urban N, McIntosh MW |
J. Clin. Oncol. |
2013 |
PLCO |
| Results of the two incidence screenings in the National Lung Screening Trial. |
24004119
|
Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J, National Lung Screening Trial Research Team |
N. Engl. J. Med. |
2013 |
NLST |
